WASHINGTON — Novo Nordisk CEO Lars Fruergaard Jørgensen will testify before the Senate after Sen. Bernie Sanders threatened to subpoena the company over its pricing
A blockbuster arthritis drug from Novartis may face a limit on what Colorado health plans pay for the medicine after a state board determined the
The market for psychedelic retreats is on a remarkable trajectory, with projections indicating it will surpass the $1 trillion mark by 2027. This anticipated milestone
The UC Berkeley Center for the Science of Psychedelics has embarked on an unprecedented study to explore why psilocybin, a psychoactive compound found in certain
A week after an FDA committee voted against recommending midomafetamine (MDMA) treatment for post-traumatic stress disorder (PTSD), Lykos Therapeutics is working to clarify the situation
AUSTIN, Texas, June 14, 2024 /PRNewswire/ — Mindbloom, the leading provider of psychedelic therapy, announced today the findings of the largest peer-reviewed study in the history of ketamine therapy and
What You Should Know: – A new study from Mount Sinai Hospital suggests artificial intelligence (AI) can significantly improve patient outcomes by predicting and preventing
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Zimmer Biomet has partnered with
Dive Brief: The Association for the Advancement of Medical Instrumentation updated its standard on ethylene oxide (EtO) sterilizers used in healthcare facilities, the organization said
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Agilent Technologies will lay off